FIDSON logo

Fidson Healthcare Plc Stock Price

NGSE:FIDSON Community·₦270.8b Market Cap
  • 2 Narratives written by author
  • 6 Comments on narratives written by author
  • 40 Fair Values set on narratives written by author

FIDSON Share Price Performance

₦93.55
52.10 (125.69%)
₦101.51
Fair Value
₦93.55
52.10 (125.69%)
7.8% undervalued intrinsic discount
₦101.51
Fair Value
Price ₦93.55
Kaiserhenry ₦101.51

FIDSON Community Narratives

Fair Value
·
Fair Value ₦101.51 7.8% undervalued intrinsic discount

Fidson Healthcare's Revenue Set to Surge by 20% Amid Nigeria's Local Pharma Boom

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

FIDSON logo

Fidson Healthcare will thrive as Nigeria leans on local pharma

Fair Value: ₦101.51 7.8% undervalued intrinsic discount
7 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with proven track record and pays a dividend.

2 Risks
3 Rewards

Fidson Healthcare Plc Key Details

₦130.9b

Revenue

₦77.2b

Cost of Revenue

₦53.7b

Gross Profit

₦42.1b

Other Expenses

₦11.6b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
4.00
41.01%
8.85%
41.5%
View Full Analysis

About FIDSON

Founded
1995
Employees
732
CEO
Abiola Adebayo
WebsiteView website
fidson.com

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, capsules, syrups, tablets, and injectables. The company also provides products for anti-infective and anti-malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is headquartered in Lagos, Nigeria.

Recent FIDSON News & Updates

Narrative Update Jul 28

Fidson Healthcare Plc Reports Strong Q1 2026 Earnings Growth Driven by Revenue Expansion and Improved Operating Efficiency

Executive Summary Analyst: Qudus Adebara (Research Analyst, DLM Capital Group) Fidson Healthcare Plc delivered a solid financial performance for the three months ended March 31, 2026, underpinned by robust revenue growth and improved operating margins. Revenue expanded significantly by 22% YoY to ₦42.60 billion, driven by strong growth in OTC products, export sales, and consumer healthcare segments.

Recent updates

No updates

Fidson Healthcare Plc Competitors